[ Back to EurekAlert! ]

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System

FDA Approval: ALS Trial

Loading video...

Caption: Dr. Eva Feldman of the University of Michigan discusses the FDA approval of a Phase II clinical trial of stem cell injections for patients with ALS, also known as Lou Gehrig's disease.

Credit: University of Michigan/Logan6

Usage Restrictions: None

Related news release: FDA approves Phase II of stem cell trial for ALS led by U-M's Dr. Eva Feldman


[ Back to EurekAlert! ]